Recent Advances in Asymmetric Catalysis Associated with B(C₆F₅)₃

Area of Science:

• Organic Chemistry
• Catalysis
• Medicinal Chemistry

Background:

• Asymmetric catalysis is crucial in modern pharmaceutical manufacturing, exemplified by (S)-Naproxen and (S)-Propranolol synthesis.
• Tris(pentafluorophenyl)borane (B(C6F5)3) possesses unique Lewis acidity and steric properties, making it highly suitable for asymmetric catalysis.

Purpose of the Study:

• To review the accelerating attention and applications of B(C6F5)3 in various asymmetric catalytic reactions.
• To highlight recent advancements in substrate activation strategies utilizing B(C6F5)3.

Main Methods:

• Review of recent literature showcasing B(C6F5)3 in asymmetric Diels-Alder cycloaddition and carbonyl-ene cyclization reactions.
• Exploration of indirect substrate activation via in situ supramolecular catalyst generation using Lewis-acid-assisted Lewis acid (LLA) and Lewis acid-assisted Brønsted acid (LBA) strategies.
• Analysis of reactions involving cooperative catalysis between chiral co-catalysts and B(C6F5)3 for direct substrate activation.

Main Results:

• B(C6F5)3 demonstrates significant utility in promoting diverse asymmetric transformations.
• Novel catalytic systems based on LLA and LBA strategies effectively utilize B(C6F5)3 for indirect substrate activation.
• Cooperative catalysis involving B(C6F5)3 offers direct substrate activation pathways.

Conclusions:

• B(C6F5)3 is a versatile and increasingly important catalyst in asymmetric synthesis.
• The development of supramolecular and cooperative catalytic systems expands the scope and efficiency of B(C6F5)3-mediated reactions.
• These advancements hold significant implications for the synthesis of chiral pharmaceuticals.